Kronos Bio, Inc. (KRON) Financials
KRON Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 238.0 million | 59.4 million |
2023-06-30 | 260.6 million | 57.3 million |
2023-03-31 | 289.0 million | 63.4 million |
2022-12-31 | 294.9 million | 50.4 million |
KRON Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -22.8 million | 6.3 million |
2023-06-30 | -25.3 million | 6.9 million |
2023-03-31 | -6.1 million | 6.6 million |
2022-12-31 | -22.6 million | 7.7 million |
KRON Net Income
No data available :(
KRON Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 186.7 million | - | 29.5 million |
2023-06-30 | 219.5 million | - | 30.2 million |
2023-03-31 | 241.3 million | - | 31.0 million |
2022-12-31 | 247.9 million | - | 31.1 million |
KRON Shares Outstanding
KRON Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 214000 | 25.3 million | 9.4 million | - |
2023-06-30 | 308000 | 22.7 million | 11.4 million | - |
2023-03-31 | 126000 | 19.7 million | 10.1 million | - |
2022-12-31 | 52000 | 23.2 million | 10.5 million | - |
KRON Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 917000 | 510000 |
2023-06-30 | 1.9 million | 1.2 million |
2023-03-31 | 1.2 million | 1.2 million |
2022-12-31 | - | 1.1 million |
KRON
Price: $1.02
52 week price:
Earnings Per Share: -1.95 USD
P/E Ratio: -0.49
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 184700
Market Capitalization: 65.5 million